2008
DOI: 10.1056/nejmoa070570
|View full text |Cite
|
Sign up to set email alerts
|

Thrombolysis during Resuscitation for Out-of-Hospital Cardiac Arrest

Abstract: When tenecteplase was used without adjunctive antithrombotic therapy during advanced life support for out-of-hospital cardiac arrest, we did not detect an improvement in outcome, in comparison with placebo. (ClinicalTrials.gov number, NCT00157261.)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
156
2
22

Year Published

2009
2009
2022
2022

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 335 publications
(187 citation statements)
references
References 35 publications
6
156
2
22
Order By: Relevance
“…The results did not show an improvement in 30-day survival for all patients, but cases with pulmonary embolism did benefit from early thrombolysis. 8 In a smaller case series and retrospective analysis of patients with pulmonary embolism undergoing CPR, 9 the patient outcomes support thrombolytic therapy when pulmonary embolism is highly suspected. Our patient had known risk factors, including a history of knee surgery with immobilisation, as well as oral contraceptive use.…”
Section: Discussionmentioning
confidence: 99%
“…The results did not show an improvement in 30-day survival for all patients, but cases with pulmonary embolism did benefit from early thrombolysis. 8 In a smaller case series and retrospective analysis of patients with pulmonary embolism undergoing CPR, 9 the patient outcomes support thrombolytic therapy when pulmonary embolism is highly suspected. Our patient had known risk factors, including a history of knee surgery with immobilisation, as well as oral contraceptive use.…”
Section: Discussionmentioning
confidence: 99%
“…For the majority of patients affected, fibrinolysis is therefore a pathophysiologically well-founded therapeutic option whose effectiveness has been shown in animal experiments (10,11). However, the positive results of several smaller prospective studies (12,13), case series studies (14,15) and one meta-analysis (16) on pre-hospital fibrinolysis in the case of OHCA could not be confirmed in a large randomised-controlled multicentre study (Thrombolysis in Cardiac Arrest, TROICA) where tenecteplase (TNK) was used (17). Possible reasons for this discrepancy between the TROICA and earlier studies include smaller effects of fibrinolysis if applied early during the course of resuscitation, differing proportions of patients with causal pulmonary embolism, lack of anti-coagulation and anti-aggregation co-medication and generally insufficient perfusion pressure during cardiopulmonary resuscitation (CPR) (17).…”
Section: Introductionmentioning
confidence: 94%
“…O estudo TROICA (Thrombolysis in Cardiac Arrest) 482 , interrompido por problemas de segurança, está contraindicando seu uso na ressuscitação cardiopulmonar. Porém, alguns relatos de administração de trombolíticos na parada cardiorrespiratória após infarto do miocárdio ou embolia pulmonar maciça têm evidenciado resultados animadores, mesmo quando esta terapêutica é utilizada como recurso extremo após falha nas medidas habituais e com ressuscitação prolongada 483,484 .…”
Section: -Terapia Trombolítica Na Parada Cardiorrespiratóriaunclassified